Treatment of Oral Submucous Fibrosis with Xanthinol Nicotinate, Dexamethasone and Levamisole.
Not Applicable
- Conditions
- Health Condition 1: K135- Oral submucous fibrosis
- Registration Number
- CTRI/2019/05/019008
- Lead Sponsor
- Dr Shaikh Saba Sultana
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Clinically diagnosed case of OSMF.
Patients within age group of 20-40 years.
Patients who were willing for follow up visits and to quit the habit of areca nut chewing.
Exclusion Criteria
Pregnant ladies and lactating mothers
Patient allergic to study drugs or with positive drug history of anticoagulants.
Previous history of OSMF treatment
Systemic diseases e.g. diabetes mellitus, hypertension, aneamic stomatitis, radiation fibrosis , scleroderma, cardiac disorders.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method interincisal mouth opening <br/ ><br>tongue protrusion <br/ ><br>burning sensationTimepoint: interincisal mouth opening <br/ ><br>tongue protrusion <br/ ><br>burning sensation will be assessed every week for 2 months
- Secondary Outcome Measures
Name Time Method fibrous band status <br/ ><br>ulceration in oral cavityTimepoint: will be assessed every week for 2 months